Rapid start means beginning antiretroviral treatment within days of diagnosis, sometimes on the same day, rather than waiting weeks for baseline results and a series of appointments. It has become standard practice in the UK and elsewhere, and it improves both individual outcomes and the prevention benefit.
What changed?
For years, treatment was deferred until the CD4 count fell below a threshold, on the reasoning that starting early exposed people to drugs before they needed them. Two large trials reported in 2015 settled the question decisively: starting treatment immediately, regardless of CD4 count, produced substantially better outcomes than waiting. Guidance changed internationally within months.
Why does starting early matter for health?
Because immune damage accumulates from the beginning and is not fully reversible. Untreated HIV causes chronic inflammation affecting the cardiovascular system, kidneys and other organs even at high CD4 counts. Starting early preserves immune function, reduces long-term complications and produces better CD4 recovery than starting after significant depletion.
Why does it matter for prevention?
Because the period between diagnosis and viral suppression is a period of transmissibility. Someone diagnosed and started on treatment within a week may be undetectable within a couple of months. Someone whose treatment start is delayed by six weeks of appointments carries an additional six weeks of transmissible infection, plus whatever suppression time follows.
What does rapid start involve?
The first prescription is issued before all baseline results are back, using a regimen chosen to be safe in almost anyone. Resistance testing, kidney and liver function, hepatitis status and other results follow, and the regimen is adjusted if needed. Modern combinations are forgiving enough that this sequencing is safe, which was less true of older drugs.
Does it improve engagement?
Yes, and this is one of the strongest arguments for it. The period between diagnosis and starting treatment is when people are most likely to disengage, and each additional appointment before a prescription is a point at which someone may not return. Getting medication into someone while they are in front of you removes several of those points.
Is anyone not suitable?
People with certain opportunistic infections, particularly cryptococcal meningitis or tuberculosis affecting the brain, may need those treated first, since starting antiretrovirals too quickly can cause a severe inflammatory reaction as the immune system recovers. This is a specialist judgement and affects a small minority, mostly people diagnosed very late.
What should you expect if newly diagnosed?
To be seen quickly, usually within a week or two and often sooner, and to leave with medication at that first or second appointment. If you are told to wait weeks, it is reasonable to ask why and whether an earlier start is possible. Most UK services are set up for this now.
Does it apply to restarting after a break?
The same logic holds. Someone returning to care after a period off treatment benefits from restarting quickly rather than waiting for a full set of results, though resistance testing matters more in that situation because the gap may have allowed resistance to develop. Ring the clinic before restarting rather than resuming an old prescription yourself.
How does this fit the broader strategy?
Testing finds the infection, rapid start shortens the gap to suppression, and suppression removes transmission. Each link tightens the sequence. Rapid start is the least visible of the three and one of the more consequential, because it compresses a window that used to be measured in months.
Does starting fast mean less choice about the regimen?
Slightly, at first. The initial combination is chosen to be safe before resistance and other results are back, which narrows the options for a few weeks. Once results arrive the regimen can be adjusted, and switching later for side effects, convenience or interactions is routine. Nothing about a rapid start locks you into a particular drug.
What if you do not feel ready?
Common, and worth saying rather than agreeing and then not taking it. A short delay to absorb the diagnosis is not a disaster, and it is better than a start that does not stick. What is worth avoiding is an open-ended postponement, since the period before treatment is the period when both your health and onward transmission are affected.